282
Views
6
CrossRef citations to date
0
Altmetric
Gastroenterology

Impact of NOD2/CARD15 polymorphisms on response to monoclonal antibody therapy in Crohn’s disease: a systematic review and meta-analysis

, , &
Pages 2007-2012 | Received 18 May 2016, Accepted 11 Aug 2016, Published online: 16 Sep 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (5)

Giacomo Cozzi, Laura Scagnellato, Mariagrazia Lorenzin, Edoardo Savarino, Fabiana Zingone, Francesca Ometto, Marta Favero, Andrea Doria, Stephan R. Vavricka & Roberta Ramonda. (2023) Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies. Nature Reviews Rheumatology 19:8, pages 503-518.
Crossref
Sophie Vieujean & Edouard Louis. (2023) Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 16, pages 175628482311733.
Crossref
Rita Lauro, Federica Mannino, Natasha Irrera, Francesco Squadrito, Domenica Altavilla, Giovanni Squadrito, Giovanni Pallio & Alessandra Bitto. (2021) Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review. Biomedicines 9:12, pages 1748.
Crossref
Irene Marafini & Giovanni Monteleone. (2021) Precision Medicine in Inflammatory Bowel Diseases. Frontiers in Pharmacology 12.
Crossref
Hussein Mahajna & Shomron Ben-Horin. (2020) Novel bio-genetic predictors of response to biologic treatment in inflammatory bowel diseases. Current Opinion in Pharmacology 55, pages 132-140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.